Therefore, we found it interesting that a prior report showed that inhibiting Erbin reduced HER2 expression and signaling within breast cancer cells and reduced the formation and growth of HER2-dependent mammary tumors in MMTV-Neu mice in a similar fashion to what we had previously shown for inhibition of Ezrin and NHERF1 [27]. Here, ERBB2 is linked to breast carcinoma.